These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2479333)

  • 1. Bimodal treatment with nimodipine and low-molecular-weight dextran for focal cerebral ischemia in the rat.
    Salgado AV; Jones SC; Furlan AJ; Korfali E; Marshall SA; Little JR
    Ann Neurol; 1989 Nov; 26(5):621-7. PubMed ID: 2479333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of nimodipine is not mediated by increased cerebral blood flow after transient forebrain ischemia in rats.
    Welsch M; Nuglisch J; Krieglstein J
    Stroke; 1990 Dec; 21(12 Suppl):IV105-7. PubMed ID: 2260131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine and the haemodynamic and histopathological consequences of middle cerebral artery occlusion in the rat.
    Gotoh O; Mohamed AA; McCulloch J; Graham DI; Harper AM; Teasdale GM
    J Cereb Blood Flow Metab; 1986 Jun; 6(3):321-31. PubMed ID: 3711159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypervolemic hemodilution in experimental focal cerebral ischemia. Elevation of cardiac output, regional cortical blood flow, and ICP after intravascular volume expansion with low molecular weight dextran.
    Wood JH; Simeone FA; Fink EA; Golden MA
    J Neurosurg; 1983 Sep; 59(3):500-9. PubMed ID: 6193256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimodipine binding in focal cerebral ischemia.
    Hogan M; Gjedde A; Hakim AM
    Stroke; 1990 Dec; 21(12 Suppl):IV78-80. PubMed ID: 2175462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of intravenous nimodipine in the treatment of focal cerebral ischemia in a primate model.
    Hadley MN; Zabramski JM; Spetzler RF; Rigamonti D; Fifield MS; Johnson PC
    Neurosurgery; 1989 Jul; 25(1):63-70. PubMed ID: 2755582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings.
    Germano IM; Bartkowski HM; Cassel ME; Pitts LH
    J Neurosurg; 1987 Jul; 67(1):81-7. PubMed ID: 3598674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nimodipine pretreatment improves cerebral blood flow and reduces brain edema in conscious rats subjected to focal cerebral ischemia.
    Jacewicz M; Brint S; Tanabe J; Wang XJ; Pulsinelli WA
    J Cereb Blood Flow Metab; 1990 Nov; 10(6):903-13. PubMed ID: 2211883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging in the evaluation of nimodipine-treated acute experimental focal cerebral ischemia.
    Germano IM; Bartkowski HM; Berry I; Moseley M; Brant-Zawadzki M; Pitts LH
    Acta Radiol Suppl; 1986; 369():49-52. PubMed ID: 2980536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral acidosis in focal ischemia: II. Nimodipine and verapamil normalize cerebral pH following middle cerebral artery occlusion in the rat.
    Hakim AM
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):676-83. PubMed ID: 3793803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimodipine prevents postischemic brain damage in the early phase of focal cerebral ischemia.
    Hara H; Nagasawa H; Kogure K
    Stroke; 1990 Dec; 21(12 Suppl):IV102-4. PubMed ID: 2260130
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of nimodipine in treatment of experimental focal cerebral ischaemia.
    Marinov M; Wassmann H; Natschev S
    Neurol Res; 1991 Jun; 13(2):77-83. PubMed ID: 1682844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury.
    Fehlings MG; Tator CH; Linden RD
    J Neurosurg; 1989 Sep; 71(3):403-16. PubMed ID: 2475595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversibility of nimodipine binding to brain in transient cerebral ischemia.
    Hogan MJ; Hakim AM
    J Neurochem; 1992 Nov; 59(5):1745-52. PubMed ID: 1402919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nimodipine and experimental combined disorders of cerebral and coronary circulation].
    Mirzoian RS; Khaĭlov NA; Tsorin IB; Gan'shina TS
    Eksp Klin Farmakol; 2009; 72(2):24-8. PubMed ID: 19441723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous nimodipine treatment attenuates cortical infarction in rats subjected to 24 hours of focal cerebral ischemia.
    Jacewicz M; Brint S; Tanabe J; Pulsinelli WA
    J Cereb Blood Flow Metab; 1990 Jan; 10(1):89-96. PubMed ID: 2298839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo uptake of [3H]nimodipine in focal cerebral ischemia: modulation by hyperglycemia.
    Osuga S; Hogan MJ
    J Cereb Blood Flow Metab; 1997 Oct; 17(10):1057-65. PubMed ID: 9346430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nimodipine on acute focal cerebral ischemia.
    Barnett GH; Bose B; Little JR; Jones SC; Friel HT
    Stroke; 1986; 17(5):884-90. PubMed ID: 3764959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo binding of nimodipine in the brain: I. The effect of focal cerebral ischemia.
    Hakim AM; Hogan MJ
    J Cereb Blood Flow Metab; 1991 Sep; 11(5):762-70. PubMed ID: 1874808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimodipine prevents hyperglycemia-induced cerebral acidosis in middle cerebral artery occluded rats.
    Berger L; Hakim AM
    J Cereb Blood Flow Metab; 1989 Feb; 9(1):58-64. PubMed ID: 2910898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.